Literature DB >> 3825738

Antagonism of histamine and leukotrienes by azelastine in isolated guinea pig ileum.

N Chand, W Diamantis, R D Sofia.   

Abstract

The effects of azelastine on histamine- and leukotriene C4 and D4 (LTC4, LTD4)-induced contractile responses in isolated guinea pig ileum were investigated. Following a 2-min contact with the ileum, azelastine produced competitive antagonism of histamine (pA2 = 8.24). Following a 15-min contact, azelastine at 2.5 X 10(-9) M exerted competitive antagonism, but at higher concentrations (10, 40 and 160 X 10(-9) M) it not only shifted histamine concentration-effect curves to the right but also suppressed its maximum. Thus, azelastine exerts a dual (competitive/noncompetitive) antagonism of histamine depending upon the concentration and duration of contact. Azelastine and FPL 55712 (a known LT receptor antagonist) produced concentration-dependent antagonism of LTC4 and LTD4. Azelastine and compound FPL 55712 also exerted concentration-dependent reversal (relaxation) of pre-existing LTC4-induced contractions. In conclusion, the potent H1-histamine and leukotriene receptor blocking activities of azelastine may contribute to its antiasthmatic/antiallergic activities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3825738     DOI: 10.1007/bf01966201

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  13 in total

1.  Quantitative studies of antagonists for 5-hydroxytryptamine.

Authors:  J H GADDUM; K A HAMEED; D E HATHWAY; F F STEPHENS
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1955-01

2.  The effect of single and multiple dose therapy with azelastine on the immediate asthmatic response to allergen provocation testing.

Authors:  S Ollier; C A Gould; R J Davies
Journal:  J Allergy Clin Immunol       Date:  1986-08       Impact factor: 10.793

Review 3.  The classification of drugs and drug receptors in isolated tissues.

Authors:  T P Kenakin
Journal:  Pharmacol Rev       Date:  1984-09       Impact factor: 25.468

4.  Lipoxygenase pathway and hydroperoxy acids: possible relevance to aspirin-induced asthma and hyperirritability of airways in asthmatics.

Authors:  N Chand; B M Altura
Journal:  Prostaglandins Med       Date:  1981-02

5.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

6.  Effects of azelastine on allergen- and exercise-induced asthma.

Authors:  S Motojima; Y Ohashi; T Otsuka; T Fukuda; S Makino
Journal:  Asian Pac J Allergy Immunol       Date:  1985-12       Impact factor: 2.310

7.  Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabbit leukocytes.

Authors:  N Chand; J Pillar; W Diamantis; R D Sofia
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

8.  A dose-response study of the bronchodilator action of azelastine in asthma.

Authors:  J P Kemp; E O Meltzer; H A Orgel; M J Welch; G A Bucholtz; E Middleton; S L Spector; J J Newton; J L Perhach
Journal:  J Allergy Clin Immunol       Date:  1987-06       Impact factor: 10.793

9.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

10.  Inhibition of passive cutaneous anaphylaxis (PCA) by azelastine: dissociation of its antiallergic activities from antihistaminic and antiserotonin properties.

Authors:  N Chand; J E Harrison; S M Rooney; R D Sofia; W Diamantis
Journal:  Int J Immunopharmacol       Date:  1985
View more
  8 in total

1.  Inhibition of cysteinyl-leukotriene production by azelastine and its biological significance.

Authors:  U Achterrath-Tuckermann; T Simmet; W Luck; I Szelenyi; B A Peskar
Journal:  Agents Actions       Date:  1988-07

2.  Azelastine inhibits bronchial hyperreactivity to acetylcholine in guinea pigs.

Authors:  U Achterrath-Tuckermann; I Szelenyi
Journal:  Experientia       Date:  1988-12-01

3.  The effect of azelastine and some other antiasthmatic and antiallergic drugs on calmodulin and protein kinase C.

Authors:  E Middleton; P Ferriola; G Drzewiecki; R D Sofia
Journal:  Agents Actions       Date:  1989-08

Review 4.  Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

5.  A placebo controlled study comparing the efficacy of intranasal azelastine and beclomethasone in the treatment of seasonal allergic rhinitis.

Authors:  G Newson-Smith; M Powell; M Baehre; S P Garnham; M T MacMahon
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

6.  Influence of epithelial removal on the antihistaminic activity of azelastine in the guinea-pig airway smooth muscles.

Authors:  Y Kamikawa
Journal:  Agents Actions       Date:  1993-11

Review 7.  The antihistamines of the nineties.

Authors:  M M Janssens; P H Howarth
Journal:  Clin Rev Allergy       Date:  1993

8.  A multicenter clinical study of the efficacy and tolerability of azelastine nasal spray in the treatment of seasonal allergic rhinitis: a comparison with oral cetirizine.

Authors:  D Charpin; P Godard; R P Garay; M Baehre; D Herman; F B Michel
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.